The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 26, 2021

Filed:

Mar. 29, 2018
Applicant:

Bristol-myers Squibb Company, Princeton, NJ (US);

Inventors:

Ke Chen, East Brunswick, NJ (US);

Joerg Deerberg, Columbus, NJ (US);

Dong Lin, Monmouth Junction, NJ (US);

Michael Dummeldinger, Plainsboro, NJ (US);

Bahar Inankur, New Brunswick, NJ (US);

Sergei Kolotuchin, Roselle Park, NJ (US);

Jun Li, Langhorne, PA (US);

Amanda J. Rogers, Asbury, NJ (US);

Victor W. Rosso, Monroe Township, NJ (US);

Eric M. Simmons, East Brunswick, NJ (US);

Daniel S. Treitler, Cranford, NJ (US);

Jianji Wang, Dayton, NJ (US);

Michael J. Smith, Somerset, NJ (US);

Tamas Benkovics, East Brunswick, NJ (US);

Assignee:

Bristol-Myers Squibb Company, Princeton, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 403/12 (2006.01); C07C 211/09 (2006.01); C07D 237/24 (2006.01); C07D 249/08 (2006.01);
U.S. Cl.
CPC ...
C07D 403/12 (2013.01); C07C 211/09 (2013.01); C07D 237/24 (2013.01); C07D 249/08 (2013.01); C07B 2200/13 (2013.01);
Abstract

The invention relates to an improved process for synthesizing 6-(cyclopropaneamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-d3)pyridazine-3-carboxamide of the formula: [INSERT CHEMICAL STRUCTURE HERE] Compound I is currently in clinical trials for the treatment of auto-immune and auto-inflammatory diseases such as psoriasis.


Find Patent Forward Citations

Loading…